malondialdehyde has been researched along with No-Reflow Phenomenon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pang, Z; Yao, Z; Zhao, W | 1 |
| Akinmoladun, AC; Barthwal, MK; Dikshit, M; Farombi, EO; Obuotor, EM | 1 |
| Acar, G; Akçay, A; Atli, Y; Kurutaş, E; Nacar, AB; Sökmen, A; Tuncer, C | 1 |
1 trial(s) available for malondialdehyde and No-Reflow Phenomenon
| Article | Year |
|---|---|
Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
Topics: Blood Pressure; Cardiotonic Agents; Coronary Disease; Creatine Kinase, MB Form; Diastole; Elective Surgical Procedures; Female; Heart Rate; Humans; Male; Malondialdehyde; Middle Aged; Nicorandil; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Peroxidase; Stroke Volume; Systole; Troponin I | 2017 |
2 other study(ies) available for malondialdehyde and No-Reflow Phenomenon
| Article | Year |
|---|---|
Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.
Topics: Anacardiaceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Catalase; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Isoproterenol; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitrites; No-Reflow Phenomenon; Phosphates; Plant Extracts; Plant Leaves; Ramipril; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors | 2010 |
Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow.
Topics: Adrenergic beta-1 Receptor Antagonists; Benzopyrans; Blood Flow Velocity; Case-Control Studies; Catalase; Coronary Circulation; Erythrocytes; Ethanolamines; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nebivolol; Nitric Oxide; No-Reflow Phenomenon; Oxidative Stress; Superoxide Dismutase; Vasodilator Agents | 2010 |